Company Focus

Biogen

Latest Biogen News

Big pharma ramps up Alzheimer’s bets with surge in billion-dollar acquisitions
Pharmaceutical
Acquisitions in Alzheimer’s drug development have soared, with deal value jumping from $2 billion in 2022 to nearly $18 billion in 2024. The trend has carried into 2025, with total disclosed acquisitions reaching $16.8 billion by May, according to GlobalData.   30 June 2025


Insights

Company Spotlight

Latest News & Features of interest to Biogen

Latest Relevant Ones To Watch News


More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search